| Study: Non-white patients less likely to qualify for Alzheimer’s drugs Verywell Health: Charles Duffy, professor at the School of Medicine, discussed anti-amyloid monoclonal antibodies for treatment of Alzheimer’s disease and diagnostic tools. “The amazing diversity and power of the brain imaging systems that are evolving today are very exciting,” Duffy said. “We have to be careful about making sure that we are not jumping to conclusions, based on what is likely not a full understanding of what these things mean.” |
